Clinical Trials List
2021-11-03 - 2025-08-25
Phase II
Terminated1
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chia-I Shen Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Yuh-Min Chen Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Chao-Hua Chiu Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
220 participants
